143 related articles for article (PubMed ID: 33043837)
1. The
De Martino M; Esposito F; Fusco A
Cell Cycle; 2020 Nov; 19(22):2955-2959. PubMed ID: 33043837
[TBL] [Abstract][Full Text] [Related]
2. HMGA1-pseudogene7 transgenic mice develop B cell lymphomas.
De Martino M; De Biase D; Forzati F; Credendino SC; Palma G; Barbieri A; Arra C; Paciello O; Gaudio E; Ponzoni M; De Vita G; Chieffi P; Bertoni F; Fusco A; Esposito F
Sci Rep; 2020 Apr; 10(1):7057. PubMed ID: 32341372
[TBL] [Abstract][Full Text] [Related]
3. Characterization of
De Martino M; Palma G; Arra C; Chieffi P; Fusco A; Esposito F
Cell Cycle; 2020 Sep; 19(18):2281-2285. PubMed ID: 32787507
[TBL] [Abstract][Full Text] [Related]
4. MYC-regulated pseudogene HMGA1P6 promotes ovarian cancer malignancy via augmenting the oncogenic HMGA1/2.
Tian X; Song J; Zhang X; Yan M; Wang S; Wang Y; Xu L; Zhao L; Wei JJ; Shao C; Kong B; Liu Z
Cell Death Dis; 2020 Mar; 11(3):167. PubMed ID: 32127525
[TBL] [Abstract][Full Text] [Related]
5. HMGA1-pseudogenes and cancer.
De Martino M; Forzati F; Arra C; Fusco A; Esposito F
Oncotarget; 2016 May; 7(19):28724-35. PubMed ID: 26895108
[TBL] [Abstract][Full Text] [Related]
6. Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas.
Fedele M; Pentimalli F; Baldassarre G; Battista S; Klein-Szanto AJ; Kenyon L; Visone R; De Martino I; Ciarmiello A; Arra C; Viglietto G; Croce CM; Fusco A
Oncogene; 2005 May; 24(21):3427-35. PubMed ID: 15735694
[TBL] [Abstract][Full Text] [Related]
7. HMGA1 in cancer: Cancer classification by location.
Wang Y; Hu L; Zheng Y; Guo L
J Cell Mol Med; 2019 Apr; 23(4):2293-2302. PubMed ID: 30614613
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of the Cdkn2a locus cooperates with HMGA1 to drive T-cell leukemogenesis.
Di Cello F; Dhara S; Hristov AC; Kowalski J; Elbahloul O; Hillion J; Roy S; Meijerink JP; Winter SS; Larson RS; Huso DL; Resar L
Leuk Lymphoma; 2013 Aug; 54(8):1762-8. PubMed ID: 23311322
[TBL] [Abstract][Full Text] [Related]
9. Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice.
Fedele M; Fidanza V; Battista S; Pentimalli F; Klein-Szanto AJ; Visone R; De Martino I; Curcio A; Morisco C; Del Vecchio L; Baldassarre G; Arra C; Viglietto G; Indolfi C; Croce CM; Fusco A
Cancer Res; 2006 Mar; 66(5):2536-43. PubMed ID: 16510570
[TBL] [Abstract][Full Text] [Related]
10. The High Mobility Group A1 (HMGA1) gene is highly overexpressed in human uterine serous carcinomas and carcinosarcomas and drives Matrix Metalloproteinase-2 (MMP-2) in a subset of tumors.
Hillion J; Roy S; Heydarian M; Cope L; Xian L; Koo M; Luo LZ; Kellyn K; Ronnett BM; Huso T; Armstrong D; Reddy K; Huso DL; Resar LMS
Gynecol Oncol; 2016 Jun; 141(3):580-587. PubMed ID: 27001612
[TBL] [Abstract][Full Text] [Related]
11. The high mobility group A1 gene: transforming inflammatory signals into cancer?
Resar LM
Cancer Res; 2010 Jan; 70(2):436-9. PubMed ID: 20068164
[TBL] [Abstract][Full Text] [Related]
12. The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo.
Karreth FA; Reschke M; Ruocco A; Ng C; Chapuy B; Léopold V; Sjoberg M; Keane TM; Verma A; Ala U; Tay Y; Wu D; Seitzer N; Velasco-Herrera Mdel C; Bothmer A; Fung J; Langellotto F; Rodig SJ; Elemento O; Shipp MA; Adams DJ; Chiarle R; Pandolfi PP
Cell; 2015 Apr; 161(2):319-32. PubMed ID: 25843629
[TBL] [Abstract][Full Text] [Related]
13. HMGA1 down-regulation is crucial for chromatin composition and a gene expression profile permitting myogenic differentiation.
Brocher J; Vogel B; Hock R
BMC Cell Biol; 2010 Aug; 11():64. PubMed ID: 20701767
[TBL] [Abstract][Full Text] [Related]
14. HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs.
Esposito F; De Martino M; Petti MG; Forzati F; Tornincasa M; Federico A; Arra C; Pierantoni GM; Fusco A
Oncotarget; 2014 Sep; 5(18):8341-54. PubMed ID: 25268743
[TBL] [Abstract][Full Text] [Related]
15. The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.
Sumter TF; Xian L; Huso T; Koo M; Chang YT; Almasri TN; Chia L; Inglis C; Reid D; Resar LM
Curr Mol Med; 2016; 16(4):353-93. PubMed ID: 26980699
[TBL] [Abstract][Full Text] [Related]
16. The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer.
Bush BM; Brock AT; Deng JA; Nelson RA; Sumter TF
Cell Biochem Funct; 2013 Apr; 31(3):228-36. PubMed ID: 22961697
[TBL] [Abstract][Full Text] [Related]
17. HMGA1 amplifies Wnt signalling and expands the intestinal stem cell compartment and Paneth cell niche.
Xian L; Georgess D; Huso T; Cope L; Belton A; Chang YT; Kuang W; Gu Q; Zhang X; Senger S; Fasano A; Huso DL; Ewald AJ; Resar LMS
Nat Commun; 2017 Apr; 8():15008. PubMed ID: 28452345
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of HMGA1 inhibits human breast cancer cell growth and metastasis in immunodeficient mice.
Di Cello F; Shin J; Harbom K; Brayton C
Biochem Biophys Res Commun; 2013 Apr; 434(1):70-4. PubMed ID: 23545254
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of
Palumbo Júnior A; de Sousa VPL; Esposito F; De Martino M; Forzati F; Moreira FCB; Simão TA; Nasciutti LE; Fusco A; Ribeiro Pinto LF; Bessa Pereira Chaves C; Meireles Da Costa N
Genes (Basel); 2019 May; 10(5):. PubMed ID: 31096664
[TBL] [Abstract][Full Text] [Related]
20. HMGA1 promoting gastric cancer oncogenic and glycolytic phenotypes by regulating c-myc expression.
Cao XP; Cao Y; Zhao H; Yin J; Hou P
Biochem Biophys Res Commun; 2019 Aug; 516(2):457-465. PubMed ID: 31229266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]